Apixaban versus warfarin in patients with atrial fibrillation.

MLA

Granger, Christopher B., et al. “Apixaban versus Warfarin in Patients with Atrial Fibrillation.” The New England Journal of Medicine, vol. 365, no. 11, Sept. 2011, pp. 981–92. EBSCOhost, https://doi.org/10.1056/NEJMoa1107039.

APA

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., Bahit, M. C., Diaz, R., Easton, J. D., Ezekowitz, J. A., Flaker, G., Garcia, D., Geraldes, M., Gersh, B. J., Golitsyn, S., … Wallentin, L. (2011). Apixaban versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine, 365(11), 981–992. https://doi.org/10.1056/NEJMoa1107039

Chicago

Granger, Christopher B, John H Alexander, John J V McMurray, Renato D Lopes, Elaine M Hylek, Michael Hanna, Hussein R Al-Khalidi, et al. 2011. “Apixaban versus Warfarin in Patients with Atrial Fibrillation.” The New England Journal of Medicine 365 (11): 981–92. doi:10.1056/NEJMoa1107039.